Chile · Delayed Price · Currency is CLP Oxiquim Statistics
Total Valuation
Oxiquim has a market cap or net worth of CLP 313.57 billion. The enterprise value is 367.53 billion.
| Market Cap | 313.57B |
| Enterprise Value | 367.53B |
Important Dates
The next estimated earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | Sep 25, 2026 |
Share Statistics
Oxiquim has 24.89 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 24.89M |
| Shares Outstanding | 24.89M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | n/a |
| Float | 6.26M |
Valuation Ratios
The trailing PE ratio is 12.41.
| PE Ratio | 12.41 |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| PB Ratio | 2.65 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | 13.24 |
| P/OCF Ratio | 8.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.40, with an EV/FCF ratio of 15.52.
| EV / Earnings | 14.54 |
| EV / Sales | 1.63 |
| EV / EBITDA | 9.40 |
| EV / EBIT | 12.55 |
| EV / FCF | 15.52 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.58.
| Current Ratio | 1.93 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 1.75 |
| Debt / FCF | 2.89 |
| Interest Coverage | 11.11 |
Financial Efficiency
Return on equity (ROE) is 21.46% and return on invested capital (ROIC) is 13.50%.
| Return on Equity (ROE) | 21.46% |
| Return on Assets (ROA) | 7.59% |
| Return on Invested Capital (ROIC) | 13.50% |
| Return on Capital Employed (ROCE) | 14.87% |
| Weighted Average Cost of Capital (WACC) | 3.95% |
| Revenue Per Employee | 560.69M |
| Profits Per Employee | 62.70M |
| Employee Count | 403 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 6.68 |
Taxes
In the past 12 months, Oxiquim has paid 6.76 billion in taxes.
| Income Tax | 6.76B |
| Effective Tax Rate | 21.10% |
Stock Price Statistics
The stock price has increased by +9.57% in the last 52 weeks. The beta is -0.02, so Oxiquim's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +9.57% |
| 50-Day Moving Average | 12,457.98 |
| 200-Day Moving Average | 12,375.73 |
| Relative Strength Index (RSI) | 99.43 |
| Average Volume (20 Days) | 59 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oxiquim had revenue of CLP 225.96 billion and earned 25.27 billion in profits. Earnings per share was 1,015.40.
| Revenue | 225.96B |
| Gross Profit | 74.39B |
| Operating Income | 29.28B |
| Pretax Income | 32.03B |
| Net Income | 25.27B |
| EBITDA | 38.61B |
| EBIT | 29.28B |
| Earnings Per Share (EPS) | 1,015.40 |
Balance Sheet
The company has 14.53 billion in cash and 68.48 billion in debt, with a net cash position of -53.95 billion or -2,167.94 per share.
| Cash & Cash Equivalents | 14.53B |
| Total Debt | 68.48B |
| Net Cash | -53.95B |
| Net Cash Per Share | -2,167.94 |
| Equity (Book Value) | 118.50B |
| Book Value Per Share | 4,761.58 |
| Working Capital | 37.19B |
Cash Flow
In the last 12 months, operating cash flow was 38.44 billion and capital expenditures -14.76 billion, giving a free cash flow of 23.68 billion.
| Operating Cash Flow | 38.44B |
| Capital Expenditures | -14.76B |
| Depreciation & Amortization | 9.32B |
| Net Borrowing | 6.98B |
| Free Cash Flow | 23.68B |
| FCF Per Share | 951.64 |
Margins
Gross margin is 32.92%, with operating and profit margins of 12.96% and 11.18%.
| Gross Margin | 32.92% |
| Operating Margin | 12.96% |
| Pretax Margin | 14.17% |
| Profit Margin | 11.18% |
| EBITDA Margin | 17.09% |
| EBIT Margin | 12.96% |
| FCF Margin | 10.48% |
Dividends & Yields
This stock pays an annual dividend of 1,085.00, which amounts to a dividend yield of 8.68%.
| Dividend Per Share | 1,085.00 |
| Dividend Yield | 8.68% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 137.13% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 8.69% |
| Earnings Yield | 8.06% |
| FCF Yield | 7.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oxiquim has an Altman Z-Score of 3.53 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.53 |
| Piotroski F-Score | 6 |